rs73527759

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001083603.3(PTCH1):​c.163G>C​(p.Asp55His) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00495 in 1,611,754 control chromosomes in the GnomAD database, including 274 homozygotes. In-silico tool predicts a benign outcome for this variant. 12/15 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.024 ( 136 hom., cov: 31)
Exomes 𝑓: 0.0029 ( 138 hom. )

Consequence

PTCH1
NM_001083603.3 missense

Scores

14

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:5O:1

Conservation

PhyloP100: 1.92
Variant links:
Genes affected
PTCH1 (HGNC:9585): (patched 1) This gene encodes a member of the patched family of proteins and a component of the hedgehog signaling pathway. Hedgehog signaling is important in embryonic development and tumorigenesis. The encoded protein is the receptor for the secreted hedgehog ligands, which include sonic hedgehog, indian hedgehog and desert hedgehog. Following binding by one of the hedgehog ligands, the encoded protein is trafficked away from the primary cilium, relieving inhibition of the G-protein-coupled receptor smoothened, which results in activation of downstream signaling. Mutations of this gene have been associated with basal cell nevus syndrome and holoprosencephaly. [provided by RefSeq, Aug 2017]

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0015723407).
BP6
Variant 9-95516658-C-G is Benign according to our data. Variant chr9-95516658-C-G is described in ClinVar as [Benign]. Clinvar id is 41769.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars. Variant chr9-95516658-C-G is described in Lovd as [Benign].
BA1
GnomAd4 highest subpopulation (AFR) allele frequency at 95% confidence interval = 0.0801 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
PTCH1NM_001083603.3 linkc.163G>C p.Asp55His missense_variant Exon 1 of 24 ENST00000437951.6 NP_001077072.1 Q13635-2
PTCH1NM_001083602.3 linkc.-187G>C 5_prime_UTR_variant Exon 1 of 24 NP_001077071.1 Q13635-3
PTCH1NM_001354919.2 linkc.-187G>C 5_prime_UTR_variant Exon 1 of 5 NP_001341848.1

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
PTCH1ENST00000437951.6 linkc.163G>C p.Asp55His missense_variant Exon 1 of 24 5 NM_001083603.3 ENSP00000389744.2 Q13635-2

Frequencies

GnomAD3 genomes
AF:
0.0243
AC:
3687
AN:
151960
Hom.:
133
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.0823
Gnomad AMI
AF:
0.00
Gnomad AMR
AF:
0.0125
Gnomad ASJ
AF:
0.00346
Gnomad EAS
AF:
0.00
Gnomad SAS
AF:
0.000622
Gnomad FIN
AF:
0.0000945
Gnomad MID
AF:
0.0158
Gnomad NFE
AF:
0.000471
Gnomad OTH
AF:
0.0191
GnomAD2 exomes
AF:
0.00664
AC:
1632
AN:
245646
AF XY:
0.00515
show subpopulations
Gnomad AFR exome
AF:
0.0856
Gnomad AMR exome
AF:
0.00586
Gnomad ASJ exome
AF:
0.00550
Gnomad EAS exome
AF:
0.00
Gnomad FIN exome
AF:
0.0000931
Gnomad NFE exome
AF:
0.000413
Gnomad OTH exome
AF:
0.00420
GnomAD4 exome
AF:
0.00294
AC:
4287
AN:
1459676
Hom.:
138
Cov.:
31
AF XY:
0.00263
AC XY:
1908
AN XY:
726138
show subpopulations
Gnomad4 AFR exome
AF:
0.0893
AC:
2978
AN:
33334
Gnomad4 AMR exome
AF:
0.00666
AC:
296
AN:
44418
Gnomad4 ASJ exome
AF:
0.00563
AC:
147
AN:
26122
Gnomad4 EAS exome
AF:
0.00
AC:
0
AN:
39614
Gnomad4 SAS exome
AF:
0.0000815
AC:
7
AN:
85936
Gnomad4 FIN exome
AF:
0.0000568
AC:
3
AN:
52854
Gnomad4 NFE exome
AF:
0.000365
AC:
406
AN:
1111378
Gnomad4 Remaining exome
AF:
0.00707
AC:
426
AN:
60264
Heterozygous variant carriers
0
222
444
667
889
1111
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Exome Het
Exome Hom
Variant carriers
0
102
204
306
408
510
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0243
AC:
3699
AN:
152078
Hom.:
136
Cov.:
31
AF XY:
0.0237
AC XY:
1762
AN XY:
74368
show subpopulations
Gnomad4 AFR
AF:
0.0824
AC:
0.0823728
AN:
0.0823728
Gnomad4 AMR
AF:
0.0124
AC:
0.0124134
AN:
0.0124134
Gnomad4 ASJ
AF:
0.00346
AC:
0.00345622
AN:
0.00345622
Gnomad4 EAS
AF:
0.00
AC:
0
AN:
0
Gnomad4 SAS
AF:
0.000622
AC:
0.000622407
AN:
0.000622407
Gnomad4 FIN
AF:
0.0000945
AC:
0.000094518
AN:
0.000094518
Gnomad4 NFE
AF:
0.000471
AC:
0.000470768
AN:
0.000470768
Gnomad4 OTH
AF:
0.0189
AC:
0.0189036
AN:
0.0189036
Heterozygous variant carriers
0
168
336
504
672
840
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance
Genome Het
Genome Hom
Variant carriers
0
38
76
114
152
190
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.00802
Hom.:
11
Bravo
AF:
0.0282
TwinsUK
AF:
0.00
AC:
0
ALSPAC
AF:
0.000259
AC:
1
ESP6500AA
AF:
0.0787
AC:
297
ESP6500EA
AF:
0.000610
AC:
5
ExAC
AF:
0.00740
AC:
894
Asia WGS
AF:
0.00693
AC:
25
AN:
3478
EpiCase
AF:
0.000382
EpiControl
AF:
0.000594

ClinVar

Significance: Benign
Submissions summary: Benign:5Other:1
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not provided Benign:3
Jul 13, 2012
Biesecker Lab/Clinical Genomics Section, National Institutes of Health
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:research

- -

-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Oct 14, 2023
ARUP Laboratories, Molecular Genetics and Genomics, ARUP Laboratories
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

- -

not specified Benign:2Other:1
Sep 19, 2013
ITMI
Significance:not provided
Review Status:no classification provided
Collection Method:reference population

- -

Oct 24, 2016
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. -

Mar 04, 2025
Center for Genomic Medicine, Rigshospitalet, Copenhagen University Hospital
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Classification criteria: BA1 -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_addAF
Benign
-0.47
T
BayesDel_noAF
Benign
-0.38
CADD
Benign
16
DANN
Benign
0.65
Eigen
Benign
-0.65
Eigen_PC
Benign
-0.69
FATHMM_MKL
Benign
0.27
N
LIST_S2
Benign
0.29
T
MetaRNN
Benign
0.0016
T
MetaSVM
Benign
-0.80
T
PROVEAN
Benign
-0.19
N
REVEL
Benign
0.14
Sift
Benign
0.072
T
Sift4G
Benign
0.18
T
Polyphen
0.042
B
Vest4
0.30
MVP
0.29
ClinPred
0.0057
T
GERP RS
3.1
Mutation Taster
=90/10
polymorphism (auto)

Splicing

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

LitVar

Below is the list of publications found by LitVar. It may be empty.

Other links and lift over

dbSNP: rs73527759; hg19: chr9-98278940; COSMIC: COSV64603597; API